Hatri Pharma Private Limited

Hatri Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TS2010PTC205106 Incorporated 21 July 2010 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹71.68 Lakh
▼ 93% YoY
Net loss · FY 2025
₹4.33 Cr
Latest filing
EBITDA · FY 2025
-₹58.15 Lakh
EBITDA margin -81.1%
Authorised capital
₹27 Cr
Registered with MCA
Paid-up capital
₹23.73 Cr
Issued & subscribed
Open charges
₹13.5 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings

About Hatri Pharma Private Limited

Data last updated:

Hatri Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 July 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TS2010PTC205106. Its GSTIN is 37AACCH4672C1ZQ (Andhra Pradesh).

The company has an authorised share capital of ₹27 Cr and a paid-up capital of ₹23.73 Cr. It is led by directors including Sumalatha Ambarapu and Rebala Rupakala.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹71.68 Lakh, a decline of 93% compared to the previous year. For the same year it recorded a net loss of ₹4.33 Cr and EBITDA of -₹58.15 Lakh (EBITDA margin -81.1%).

As per MCA filings, the company has open charges of ₹13.5 Cr on record. Court records list 13 cases involving the company, including 1 filed by the company and 12 filed against it; 12 cases are pending.

Hatri Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-08-0028966). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232TS2010PTC205106
Registration Number 205106
Incorporation Date 21 July 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-08-0028966

CIN history

Hatri Pharma has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232TS2010PTC205106, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TS2010PTC205106Current
U24232TG2010PTC069596Previous
U24232AP2010PTC116314Previous
U24232AP2010PTC069596Previous

Recognitions & Rankings of Hatri Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-AP-08-0028966

Contact details

Hatri Pharma Private Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    Plot No.16 2nd Floor, Durga Shakti Peetam Prashanthi Nagar, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Hatri Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Hatri Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Hatri Pharma Private Limited, buy the company report.

Financials of Hatri Pharma Private Limited

FY 2025 filings available

Hatri Pharma Private Limited reported revenue of ₹71.68 Lakh (down 93% YoY) for FY 2025.

Revenue · FY 2025
₹71.68 Lakh ▼ 93%
Net loss · FY 2025
₹4.33 Cr
EBITDA · FY 2025
-₹58.15 Lakh margin -81.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 93%
EBITDA CAGR growth
1 year
▼ 214%

Revenue fell 93% in the latest year. EBITDA fell 214% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹58.15 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹4.33 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-81.1%
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hatri Pharma Private Limited, buy the company report.

Board of directors of Hatri Pharma Private Limited

Hatri Pharma has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sumalatha AmbarapuDirector09 Aug 20233 Years 3 MonthsCurrent
Rebala RupakalaDirector30 Oct 20179 Years 0 MonthsCurrent
Mohan Reddy EnaganuriDirector21 Jul 201016 Years 3 MonthsCurrent

Peer comparison

Hatri Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Alder Research Chemicals Private Limited₹77.52 Lakh (FY 2024)-20.0%Khammam, Telangana, India
Mansfield Pharma Private Limited₹77.51 Lakh (FY 2024)314.0%Hyderabad, Telangana, India
Auronext Pharma Private Limited₹75.75 Lakh (FY 2023)23.0%Hyderabad, Telangana, India
Hatri Pharma Private Limitedthis company₹71.68 Lakh (FY 2025)-₹4.33 Cr-93.0%Hyderabad, Telangana, India

To see the full peer comparison of Hatri Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹13.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹13.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Sep 2020100378112Others₹13.5 CrOpen

Total charge records: 1 View all charges

Credit ratings & regulatory alerts

Hatri Pharma Private Limited was last rated by Crisil on 09 Apr 2020.

Rating agencyRated onRating
Crisil09 Apr 2020

To see the full credit ratings and regulatory alerts of Hatri Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hatri Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Hatri Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AACCH4672C1ZQAndhra PradeshActive22 Jun 2019

To see the full GST registrations and return filing status of Hatri Pharma Private Limited, buy the company report.

Recent activity

Hatri Pharma Private Limited has 10 board changes on record since 2010: 3 appointments and 7 cessations. The latest: Archana Guddeti ceased to be Director on 03 Jun 2025.

AGM
Hatri Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Ceased
Archana Guddeti ceased to be Director.
Ceased
Dayakar Reddy Vangala ceased to be Director.
Ceased
Ravindra Reddy Paidimarla ceased to be Director.
Filing
Hatri Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Hari Gunnam ceased to be Director.
Ceased
Janga Sailaja ceased to be Director.
Ceased
Sreenivasulu Janga ceased to be Director.
Appointed
Sumalatha Ambarapu was appointed as Director.
Charges
A charge with Others amounted to Rs. 13.50 Cr with Charge ID 100378112 was registered on 23 Sep 2020.
Ceased
Vijender Medamoni ceased to be Director.
Appointed
Rebala Rupakala was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Hatri Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 July 2010 (16+ years old) and is registered under CIN U24232TS2010PTC205106.

Hatri Pharma has 3 current directors:

The latest financial statements of Hatri Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Hatri Pharma is 37AACCH4672C1ZQ, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Hatri Pharma is U24232TS2010PTC205106. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hatri Pharma has 13 court cases on record: 1 filed by the company and 12 filed against it. 12 are pending. Most are in the district courts.

Hatri Pharma was incorporated on 21 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Hatri Pharma by revenue are Alder Research Chemicals Private Limited, Mansfield Pharma Private Limited, Auronext Pharma Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Archana Guddeti ceased to be Director on 03 Jun 2025. Dayakar Reddy Vangala ceased to be Director on 20 May 2025. Ravindra Reddy Paidimarla ceased to be Director on 20 May 2025. Hatri Pharma has 10 board changes on record in total.

Yes, Hatri Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-08-0028966).

The registered office of Hatri Pharma is at Plot No.16 2nd Floor, Durga Shakti Peetam Prashanthi Nagar, Hyderabad, Telangana, India – 500072.